Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

about

Role of Bcl-2 -938 C>A polymorphism in susceptibility and prognosis of cancer: a meta-analysis.

P2860

Q37741375-A68248D2-9F0A-47B6-AF38-1D91D97FE8D6

P2860

Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

Item

http://www.wikidata.org/entity/Q42134533

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

@en

Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

@nl

type

Item

label

Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

@en

Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

@nl

prefLabel

Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

@en

Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

@nl

P1476

Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

@en

P2093

Fiona E Craig

http://www.w3.org/2001/XMLSchema#string

Rachel L Sargent

http://www.w3.org/2001/XMLSchema#string

Steven H Swerdlow

http://www.w3.org/2001/XMLSchema#string

P2860

CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

miR-15 and miR-16 induce apoptosis by targeting BCL2

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

B-cell chronic lymphocytic leukemia: a bird of a different feather

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.

The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.

New views of BCR structure and organization.

Bcl-2 and apoptosis in chronic lymphocytic leukemia.

P304

574-582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19636404

http://www.w3.org/2001/XMLSchema#string

P921

lymphocyte

P932

2713455

http://www.w3.org/2001/XMLSchema#string

Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

about

P2860

P2860

Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932